Salim Dhanji
Algemeen Directeur bij ME THERAPEUTICS HOLDINGS INC.
Vermogen: 20 M $ op 30-04-2024
Actieve functies van Salim Dhanji
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Directeur/Bestuurslid | 09-03-2023 | - |
| Algemeen Directeur | 09-03-2023 | - |
Loopbaan van Salim Dhanji
Eerdere bekende functies van Salim Dhanji
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Corporate Officer/Principal | 01-01-2009 | 01-01-2014 |
Opleiding van Salim Dhanji
| University of British Columbia | Doctorate Degree |
Statistieken
Internationaal
| Canada | 4 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Beurs
- Insiders
- Salim Dhanji
- Ervaring